|
gptkbp:instance_of
|
gptkb:Sannin
|
|
gptkbp:approves
|
gptkb:2000
|
|
gptkbp:atccode
|
N06 BA04
|
|
gptkbp:brand
|
gptkb:Methylin
gptkb:Ritalin
Metadate
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:clinical_trial
|
safety profile
pediatric use
long-term efficacy
ADHD treatment
|
|
gptkbp:code
|
00406-1001
00406-1002
00406-1003
|
|
gptkbp:contraindication
|
gptkb:Ophthalmology
heart problems
hyperthyroidism
|
|
gptkbp:dosage_form
|
gptkb:capsule
|
|
gptkbp:financial_support
|
avoid alcohol
take with food
monitor for mood changes
report any heart issues
do not stop abruptly
|
|
gptkbp:form
|
extended-release capsule
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Metadate CD
|
|
gptkbp:ingredients
|
gptkb:Sannin
|
|
gptkbp:interacts_with
|
antidepressants
MAO inhibitors
antihypertensives
anticonvulsants
|
|
gptkbp:legal_status
|
Prescription only
|
|
gptkbp:lifespan
|
3 to 4 hours
extended-release formulation
|
|
gptkbp:manufacturer
|
gptkb:UCB,_Inc.
|
|
gptkbp:packaging
|
gptkb:bottle
|
|
gptkbp:pharmacokinetics
|
hepatic metabolism
renal excretion
oral absorption
CNS stimulant
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:side_effect
|
headache
decreased appetite
insomnia
dry mouth
nervousness
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:strength
|
10 mg
20 mg
30 mg
|
|
gptkbp:structure
|
C14 H19 NO2
|
|
gptkbp:used_for
|
gptkb:Attention_Deficit_Hyperactivity_Disorder
|
|
gptkbp:bfsParent
|
gptkb:Sannin
|
|
gptkbp:bfsLayer
|
5
|